From startups to legacy brands, you're making your mark. We're here to help.
Key Links
Prepare for future growth with customized loan services, succession planning and capital for business equipment.
Key Links
Serving the world's largest corporate clients and institutional investors, we support the entire investment cycle with market-leading research, analytics, execution and investor services.
Key Links
Providing investment banking solutions, including mergers and acquisitions, capital raising and risk management, for a broad range of corporations, institutions and governments.
Your partner for commerce, receivables, cross-currency, working capital, blockchain, liquidity and more.
Key Links
A uniquely elevated private banking experience shaped around you.
Whether you want to invest on your own or work with an advisor to design a personalized investment strategy, we have opportunities for every investor.
Explore a variety of insights.
Key Links
Insights by Topic
Explore a variety of insights organized by different topics.
Key Links
Insights by Type
Explore a variety of insights organized by different types of content and media.
Key Links
We aim to be the most respected financial services firm in the world, serving corporations and individuals in more than 100 countries.
Key Links
Shanghai, October 15, 2025 – J.P. Morgan will host its fifth Global Healthcare Shanghai Conference on October 16 and October 17.
As part of the International Biopharma Industry Week Shanghai 2025, the conference will bring together leading experts from the healthcare sector and capital markets from across the world to discuss topics including key trends in healthcare investment, innovation, capital raising and China’s own healthcare industry. Over 170 one-on-one or small group meetings will also be held in parallel to the plenary session.
Rita Chan, Co-SCO for J.P. Morgan China, said: “China’s healthcare sector has seen a remarkable surge in 2025, fueled by strong momentum in out-licensing deals of innovative drugs, solid fundamentals of Chinese biotech and pharmaceutical companies, and a favorable domestic policy environment. We are confident that this year’s conference will continue to provide a unique platform for business leaders and investors to better understand the evolving landscape, share ideas, and find new opportunities in healthcare industry in China and globally.”
Alan Ho, Co-SCO for J.P. Morgan China, said: “We are upbeat about the healthcare market in China, the second largest one in the world. Drawing on our deep insights and expertise within this critical sector, J.P. Morgan is pleased to host the Global Healthcare Shanghai Conference for the fifth consecutive year, continuously connecting China with the global healthcare sectors, which we hope will help deliver benefits to more patients across the world.”
Shanghai is an important hub for the healthcare sector in China, with strong research and innovation capabilities. In recent years, Shanghai-based innovative pharmaceutical companies have ranked top in China in terms of both the number of financing transactions and the total amount of financing received.
David PW Lau, head of APAC Healthcare Investment Banking and co-head of China Investment Banking at J.P. Morgan, said: “Investor interest in Chinese healthcare companies has been growing as result of China’s vast population and rapidly expanding healthcare market, as well as Chinese companies’ enhanced innovation capabilities and globally recognized clinical data. As one of the leading investment banks in the global and China’s healthcare industry, we will continue to invest in our healthcare investment banking services to better support our clients both onshore and offshore.”
J.P. Morgan is the host of the world’s largest healthcare investment symposium – the J.P. Morgan Healthcare Conference held in San Francisco every year. This premier conference is the largest and most informative of its kind in the industry, which connects global industry leaders, emerging fast-growth companies, innovative technology creators and members of the investment community. This year, the 43nd edition of the conference brought together more than 600 companies, both public and private, as well as 8,000 delegates.
You're now leaving J.P. Morgan
J.P. Morgan’s website and/or mobile terms, privacy and security policies don’t apply to the site or app you're about to visit. Please review its terms, privacy and security policies to see how they apply to you. J.P. Morgan isn’t responsible for (and doesn’t provide) any products, services or content at this third-party site or app, except for products and services that explicitly carry the J.P. Morgan name.